Stockscreener 앱 받기
1.59
6.71%
0.10
시간 외 거래:
1.50
-0.09
-5.66%
Invo Fertility Inc 주식(IVF)의 최신 뉴스
IVF SEC FilingsINVO Fertility, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
INVO Fertility, Inc. 2025 10-K/A: Executive Compensation, Governance, and Financial Disclosures - Minichart
INVO Fertility (Nasdaq: IVF) updates 2025 10-K with pay, equity and restatement details - Stock Titan
INVO Fertility (IVF) Holds Gains, Faces Key Resistance Near $1.48Breakaway Gap - newsline.com
INVO Reverse Split: My Take On The 8-K Oklo Stock (Um5ahNsNst) - Fathom Journal
INVO Fertility Inc. (IVF) Q4 2025 Earnings: Significant EPS Miss Amidst Unreported RevenueEarnings Whisper Number - newsline.com
IVF Q3 2025 Earnings: Staggering EPS Miss Highlights Deep Financial DistressReturn On Capital - newsline.com
IVF Technical Analysis | Trend, Signals & Chart Patterns | INVO FERTILITY INC (NASDAQ:IVF) - ChartMill
INVO Fertility receives Nasdaq delisting notice for late filings By Investing.com - Investing.com Australia
INVO Bioscience Inc stock (US44984F1049): Nasdaq notice on late 10-Q filing and FY 2025 update - AD HOC NEWS
INVO Fertility receives Nasdaq delisting notice for late filings - Investing.com
INVO Fertility, Inc. Receives Nasdaq Delinquency Notice for Filing Violations - Quiver Quantitative
INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q - The Manila Times
INVO Fertility, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
INVO Fertility, Inc. Files Form 8-K with NASDAQ Listing Details and Corporate Information – June 2026 - Minichart
INVO Fertility Reports 2025 Financial Results, Strengthens Balance Sheet, and Expands Clinic Network - Minichart
INVO Fertility to restate 2025 quarterly financials due to accounting errors By Investing.com - Investing.com India
INVO Fertility to restate 2025 quarterly financials due to accounting errors - Investing.com
INVO Fertility Announces Fiscal Year 2025 Financial Results - The Manila Times
INVO Fertility FY2025 revenue rises 5% on clinic acquisition - TradingView
INVO Fertility, Inc. FY 2025: Revenue $6.84M, EPS $(214.64) — 10-K Summary - TradingView
INVO Fertility: Revenue up 5% and net loss narrowed as four-clinic network and balance sheet strengthened - TradingView
INVO Fertility (IVF) 2025 revenue rises 5% as net loss widens sharply - Stock Titan
INVO Fertility To Restate Unaudited Financials For Q1, Q2, And Q3 2025SEC Filing - TradingView
INVO Fertility: Revenue rose 5% to $6.8M, but net loss from continuing operations was $5.3M in 2025 - TradingView
INVO Fertility (IVF) 10-K shows clinic growth but highlights going-concern risk - Stock Titan
INVO Fertility (NASDAQ: IVF) flags 2025 quarterly errors, plans restatement - Stock Titan
Press Release: INVO Fertility Announces Fiscal Year 2025 Financial Results - Moomoo
INVO Fertility, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
IVF Extends Volatile Rebound As Traders Eye Weak Fundamentals - timothysykes.com
INVO Fertility (IVF) Surges 10.6%: Technical Breakout or Temporary Rally?Inside Day Breakout - newsline.com
INVO Fertility up 14%; small IVF name faces filing risk - TechStock²
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
INVO Fertility (IVF) Gains 2.94% as Shares Approach Key Resistance LevelLast Point Resistance - The Legal Advocate
IVF Q3 2025 Earnings: EPS Misses Estimates by Wide Margin; Stock Rises $3.75Geographic Revenue Trends - The Legal Advocate
INVO Fertility Stock Slides After Filing Delay - Bez Kabli
INVO Fertility Inc. (IVF) Q3 2025 Earnings: Significant EPS Miss, No Revenue ReportedEarnings Forecast Report - The Legal Advocate
INVO Fertility Q3 2025 Earnings: Massive EPS Miss as Losses WidenRevenue Miss Report - Newser
INVO Bioscience Inc stock (US44984F1049): fertility player updates investors after financing move - AD HOC NEWS
INVO Fertility (IVF) Stock: Slides -6.55%, Support at $1.49 2026-05-21Put Support - Newser
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
INVO Fertility Discloses Delay In Quarterly Filing - TipRanks
INVO Fertility (IVF) files late‑filing notice after auditor change - Stock Titan
INVO Bioscience stock (US44984F1049): merger story, Nasdaq relisting and fertility-tech ambitions - AD HOC NEWS
Armistice Capital (NASDAQ: IVF) reports 9.99% ownership in INVO - Stock Titan
INVO Fertility Inc expected to post a loss of $2.75 a shareEarnings Preview - TradingView
Number of shareholders of INVO Fertility, Inc. – NASDAQ:IVF - TradingView
INVO Fertility (IVF) Stalls at $$1.57 — Consolidation Phase 2026-05-14Real Trader Network - newser.com
INVO Fertility, Inc (IVF) Eps Diluted (TTM) - Zacks Investment Research
The valuation case for INVO Fertility (IVF) that is hard to ignore (-4.23%) 2026-05-06Profit Potential - newser.com
2.43%
자본화:
|
볼륨(24시간):